Insider · CIK 0001757533

REICIN ALISE

Reports to the SEC for 5 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001757533

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-25	TECXTectonic Therapeutic, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,545 sh	$23.67	−$36.6K	309,078
2026-09-03	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+69.3K sh	—	—	69,250
2026-06-20	TECXTectonic Therapeutic, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−924 sh	$30.34	−$28K	310,623
2026-06-16	IMTXImmatics N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+48K sh	—	—	48,000
2026-06-04	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+90K sh	—	—	90,000
2026-03-04	TECXTectonic Therapeutic, Inc.A Award	Director, Chief Executive Officer	AAward	+76.5K sh	—	—	311,547
2026-03-04	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+69.3K sh	—	—	69,250
2026-02-11	TECXTectonic Therapeutic, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,500 sh	$21.10	+$52.8K	237,547
2026-02-11	TECXTectonic Therapeutic, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,500 sh	$21.10	+$52.8K	127,030
2026-02-04	TECXTectonic Therapeutic, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,104 sh	$23.22	−$95.3K	235,047
2025-12-31	TECXTectonic Therapeutic, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+11K sh	$2.38	+$26.1K	239,151
2025-12-31	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−11K sh	—	—	22,957
2025-09-25	TECXTectonic Therapeutic, Inc.A Award	Director, Chief Executive Officer	AAward	+14.7K sh	—	—	228,185
2025-09-25	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+26.7K sh	—	—	26,710
2025-06-20	TECXTectonic Therapeutic, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−859 sh	$19.81	−$17K	213,485
2025-06-05	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2025-02-04	TECXTectonic Therapeutic, Inc.A Award	Director, Chief Executive Officer	AAward	+36K sh	—	—	214,344
2025-02-04	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+102K sh	—	—	101,953
2024-12-04	TECXTectonic Therapeutic, Inc.A Award	Director, Chief Executive Officer	AAward	+11.7K sh	—	—	178,297
2024-12-04	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+6,000 sh	—	—	6,000
2024-06-20	TECXTectonic Therapeutic, Inc.A Award	Director, Chief Executive Officer	AAward	+167K sh	—	—	166,580
2024-06-20	TECXTectonic Therapeutic, Inc.A Award	Director, Chief Executive Officer	AAward	+125K sh	—	—	124,530
2024-06-20	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+33.9K sh	—	—	33,923
2024-06-20	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+23.4K sh	—	—	23,380
2024-06-20	TECXTectonic Therapeutic, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+290K sh	—	—	289,600
2024-06-06	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2024-06-06	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+54.3K sh	—	—	54,278
2023-06-14	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2023-06-08	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2022-06-15	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-06	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2021-06-17	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-02-03	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2021-02-03	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,795
2020-06-10	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2019-11-20	CELGENE CORP /DE/A Award	PRES., GLOBAL CLINICAL DEV.	AAward	+4,298 sh	—	—	11,479
2019-11-20	CELGENE CORP /DE/A Award	PRES., GLOBAL CLINICAL DEV.	AAward	+8,927 sh	—	—	20,406
2019-11-20	CELGENE CORP /DE/A Award	PRES., GLOBAL CLINICAL DEV.	AAward	+24.2K sh	—	—	44,615
2019-11-20	CELGENE CORP /DE/D Disposition to Issuer	PRES., GLOBAL CLINICAL DEV.	DDisposition to Issuer	−44.6K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	PRES., GLOBAL CLINICAL DEV.	DDisposition to Issuer	−42.5K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Restricted Stock UnitD Disposition to Issuer	PRES., GLOBAL CLINICAL DEV.	DDisposition to Issuer	−23.8K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Restricted Stock UnitD Disposition to Issuer	PRES., GLOBAL CLINICAL DEV.	DDisposition to Issuer	−37.7K sh	—	—	0
2019-11-01	CELGENE CORP /DE/M Exercise/Conversion	PRES., GLOBAL CLINICAL DEV.	MExercise/Conversion	+11.9K sh	—	—	11,903
2019-11-01	CELGENE CORP /DE/F Tax Payment	PRES., GLOBAL CLINICAL DEV.	FTax Payment	−4,722 sh	$108.53	−$512K	7,181
2019-11-01	CELGENE CORP /DE/Restricted Stock UnitM Exercise/Conversion	PRES., GLOBAL CLINICAL DEV.	MExercise/Conversion	−11.9K sh	—	—	23,807
2019-07-11	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+31.2K sh	—	—	31,160
2019-03-01	CELGENE CORP /DE/Restricted Stock UnitA Award	PRES., GLOBAL CLINICAL DEV.	AAward	+37.7K sh	—	—	37,660
2018-11-01	CELGENE CORP /DE/Stock Option (right to buy)A Award	PRES., GLOBAL CLINICAL DEV.	AAward	+42.5K sh	—	—	42,500
2018-11-01	CELGENE CORP /DE/Restricted Stock UnitA Award	PRES., GLOBAL CLINICAL DEV.	AAward	+35.7K sh	—	—	35,710

Recent filings

Accepted (ET)
Oct 24
REICIN ALISE0001757533-26-000016
SEC(opens sec.gov)
Sep 84
REICIN ALISE0001757533-26-000014
SEC(opens sec.gov)
Jun 234
REICIN ALISE0001757533-26-000012
SEC(opens sec.gov)
Jun 184
REICIN ALISE0000950103-26-009244
SEC(opens sec.gov)
Jun 54
REICIN ALISE0001757533-26-000011
SEC(opens sec.gov)
Mar 54
REICIN ALISE0001757533-26-000009
SEC(opens sec.gov)
Mar 54/A
REICIN ALISE0001757533-26-000008
SEC(opens sec.gov)
Feb 124
REICIN ALISE0001757533-26-000005
SEC(opens sec.gov)
Feb 104
REICIN ALISE0001757533-26-000004
SEC(opens sec.gov)
Jan 54
REICIN ALISE0001757533-26-000002
SEC(opens sec.gov)
Sep 294
REICIN ALISE0001757533-25-000004
SEC(opens sec.gov)
Jun 244
REICIN ALISE0001415889-25-018106
SEC(opens sec.gov)
Jun 94
REICIN ALISE0001562180-25-004643
SEC(opens sec.gov)
Feb 64
REICIN ALISE0001415889-25-003225
SEC(opens sec.gov)
Dec 64
REICIN ALISE0001415889-24-028516
SEC(opens sec.gov)

Companies

Address

C/O TECTONIC THERAPEUTIC, INC. 490 ARSENAL WAY, SUITE 200

WATERTOWN, MA, 02472